NCI-H2122 Cell Line

Product Name	NCI-H2122 Cell Line
Cat.No	RWT-545
Size	1*10^6 cells/vial
Description	NCI-H2122 Cell Line was established from pleural effusion metastasis of lung.
Tissue	lung; derived from metastatic site: pleural effusion
Species	Homo sapiens, human
Gender	female, 46 years, Caucasian, White
Disease	stage 4, adenocarcinoma; non-small cell lung cancer
Biosafety Level	BSL 1. Runtogen determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.
Morphology	mixed morphology of rounded cells and epithelial cells. This cell line produces moderate to large, viable, loose, grape-like clusters that either loosely adhere to the flask or remain in suspension
Culture Method	RPMI-1640+10%FBS
Quality Control	NCI-H2122 Cell Line is negative for mycoplasma, bacteria, yeast, and fungi.
Shipping	Cryopreserved cells are shipped with dry ice
Storage	Upon arrival, Check all containers for leakage or breakage. Remove the frozen cells from the dry ice packaging and immediately place the cells at a temperature below -130°C, preferably in liquid nitrogen vapor, until ready for use.
Warranty	NCI-H2122 Cell Line is warranted for 30 days from the date of shipment, provided that the customer has stored and handled the product according to the information included on the product datasheet, website, and COA.
Disclaimers	Our cell line product is intended for laboratory research use only. It is not intended for any human or animal therapeutic use, any animal or human consumption, or any diagnostic use. Any proposed commercial use is prohibited without a license from Runtogen.

NCI-H2122 Cell Line

Online Inquiry

Online Inquiry